Skip to main content
. 2021 Nov 29;13(23):6000. doi: 10.3390/cancers13236000
AICD Activation-induced cell death
APC Antigen presenting cell
BiTE Bispecific T cell engager
CAIX Carbonic anhydrase IX
CAR Chimeric antigen receptor
CEA Carcinoembryonic antigen
CTLA-4 Cytotoxic T lymphocyte-associated antigen-4
DC Dendritic cell
FDA Drug Administration (FDA)
FRβ Folate receptor beta
HIF1-α Hypoxia-inducible factor 1-α
HLA Human leukocyte antigen
H2O2 Hydrogen peroxide
HVEM Herpes virus entry mediator
IL Interleukin
IV Intravenous
LAG-3 Lymphocyte activation gene-3
MCP Macrophage chemotactic protein
MDSC Myeloid-derived suppressor cell
MHC Major histocompatibility complex
MHRA Medicines and Healthcare products Regulatory Agency
MMP Matrix metalloproteinases
NK Natural killer
NSCLC Non-small cell lung cancer
PAMP Pathogen-associated molecular pattern
PD Programmed death receptor
PD-L Programmed death receptor ligand
PRR Pattern recognition receptor
SCID Severe combined immunodeficiency disease
TAM Tumour-associated macrophage
TGFβ Transforming growth factor-β
TIGIT T cell immunoglobulin and ITIM domain
TIM-3 T cell immunoglobulin and mucin-domain containing-3
TME Tumour microenvironment
Tregs T regulatory cells
VEGF Vascular endothelial growth factor
VISTA V-domain Ig suppressor of T cell activation